J&J joins Pfizer in detailing impact of Part D redesign
Bio Pharma Dive
JANUARY 22, 2025
The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the Inflation Reduction Act.
Bio Pharma Dive
JANUARY 22, 2025
The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the Inflation Reduction Act.
Rethinking Clinical Trials
JANUARY 22, 2025
In this Friday’s PCT Grand Rounds, Jeffrey Samet of Boston University will present “The HEALing Communities Study10 Million People, 67 Communities: A Community-Based Cluster Randomized Trial to Reduce Opioid Overdose Deaths.” The Grand Rounds session will be held on Friday, January 24, 2025, at 1:00 pm eastern. Samet is the John Noble Professor in General Internal Medicine at the Boston University Chobanian and Avedisian School of Medicine and and a professor of public health a
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 22, 2025
CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, one of its top-sellers.
Drug Channels
JANUARY 22, 2025
For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. You can find our updated counting below. As youll see below, the combination of formulary exclusion and private labels is creating an increasingly confusing and crowded biosimilar marketplace.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
JANUARY 22, 2025
The Unseen Heroes of Generic Drug Manufacturing: Good Manufacturing Practice (GMP) As we navigate the complex world of generic drug manufacturing, it's easy to overlook the unsung heroes that ensure the quality and safety of these life-saving medications. I'm talking about Good Manufacturing Practice (GMP), a set of guidelines that govern the production, testing, and packaging of generic drugs.
Bio Pharma Dive
JANUARY 22, 2025
The biotech said it has dosed the first participant in a Phase 3 study of its in vivo gene editing treatment. Elsewhere, the FDA imposed a hold on Atara and lifted another on Amylyx.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
ACRP blog
JANUARY 22, 2025
Independent investigators play a vital role in advancing translational “bench to bedside” research to improve human health. Setting up an investigator-initiated research program (IIRP) can encourage and support these investigators while fostering an institutions high-quality research and compliance. The Hackensack Meridian Health (HMH) Research Institutes IIRP uses a structured, integrated team approach to support independent investigators.
Pharmaceutical Technology
JANUARY 22, 2025
The FDAs decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.
Pharma Times
JANUARY 22, 2025
NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care
Pharmaceutical Technology
JANUARY 22, 2025
Glox Therapeutics is set to receive a share of the 3m ($3.67m) Collaborative Discovery Programme (CDP) funding.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
XTalks
JANUARY 22, 2025
In this episode, Ayesha spoke with Amit Etkin, Founder, President and CEO of Alto Neuroscience , a company developing precision treatments for neuropsychiatric conditions. Alto Neuroscience is focused on designing candidates that target core brain processes in patient populations not adequately treated by currently available medications. Alto is currently pursuing candidates in major depressive disorder (MDD), bipolar depression and schizophrenia.
Pharmaceutical Technology
JANUARY 22, 2025
Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.
pharmaphorum
JANUARY 22, 2025
The UK government has launched a 150 million procurement drive for artificial intelligence tools that can be used by the NHS.
Pharmaceutical Technology
JANUARY 22, 2025
The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for Ebvallo.
pharmaphorum
JANUARY 22, 2025
A UK alliance between data scientists, clinical researchers, and community opticians hopes to develop an AI to predict dementia during an eye test.
Pharmaceutical Technology
JANUARY 22, 2025
Catalent has entered a strategic partnership with Galapagos to facilitate decentralised manufacturing for the latters GLPG5101.
Drug Patent Watch
JANUARY 22, 2025
The Unseen Journey of Generic Drugs: A Look into the Regulatory Pathway Have you ever wondered how generic drugs make it to the market? It's a complex process that involves navigating a series of regulatory hurdles. As a healthcare professional or a pharmaceutical enthusiast, understanding the pathway to generic drug approval can be fascinating. The journey begins with the original patent holder filing for a new drug application (NDA) with the FDA.
Pharmaceutical Technology
JANUARY 22, 2025
The US FDA has granted breakthrough therapy designation to Bluejay Therapeutics brelovitug, to treat chronic hepatitis delta (CHD).
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
JANUARY 22, 2025
Johnson & Johnson's Spravato has become the first standalone drug to be cleared by the FDA for adults with treatment-resistant depression
Pharmaceutical Commerce
JANUARY 22, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes the importance of the patient within the pharma supply chain.
pharmaphorum
JANUARY 22, 2025
Discover the key trends and innovations shaping the pharma and life sciences industries in 2025, focusing on efficiency, patient care, customer experience, and advancements in rare disease treatments.
Pharmaceutical Commerce
JANUARY 22, 2025
The latest news for pharma industry insiders.
Trialfacts
JANUARY 22, 2025
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Center Research Center: Florida International University Location: This is a virtual research study in Miami Lead Researcher: Dr. Olatokunbo Osibogun IRB: This study has been reviewed and approved by the Florida International University Institutional Review Board About the Study Why is quitting cigarettes so challenging for those who also use e-cigarettes?
pharmaphorum
JANUARY 22, 2025
Explore the top 5 key takeaways from JP Morgan's 2025 report, covering market access, IRAs, China, AI, and women's health. Stay informed on the latest trends and developments in the financial and healthcare industries.
Pharmaceutical Commerce
JANUARY 22, 2025
What factors influence their likelihood of receiving this form of obesity treatment?
pharmaphorum
JANUARY 22, 2025
Explore the in-depth video interview with Marianne De Backer during JP Morgan Week 2025 where she discusses her insights and perspectives on the future of the financial industry.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
XTalks
JANUARY 22, 2025
The heart and vascular medication market continues to be a critical focus area for pharma companies, with billions of dollars in sales generated annually. These medications play a vital role in managing conditions such as heart failure, atrial fibrillation, stroke prevention and cholesterol reduction, improving patient outcomes and quality of life worldwide.
pharmaphorum
JANUARY 22, 2025
Discover how EEG technology is shaping the future of precision psychiatry and revolutionising mental health treatment. Explore the latest advancements and possibilities in this cutting-edge field.
Bioengineer
JANUARY 22, 2025
A groundbreaking study published in The BMJ has revealed that prehabilitationa proactive approach aimed at enhancing a patients physical and mental condition before surgeryholds significant promise in improving surgical outcomes. The research, led by Dr. Daniel McIsaac, an anesthesiologist and senior scientist at The Ottawa Hospital, compiles data from over 15,000 patients involved in 186 randomized clinical trials internationally.
pharmaphorum
JANUARY 22, 2025
Learn more about HPV self-collection, a step closer to eliminating cervical cancer, and its importance in early detection and prevention. Find out how this simple test can save lives.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content